MeiraGTx Holdings plc (MGTX) |
|
18.88 -1.61 (-7.86%)
|
02-14 16:00 |
|
Open: |
20.48 |
Pre. Close: |
20.49 |
|
High:
|
20.48 |
Low:
|
18.5 |
|
Volume:
|
166,852 |
Market Cap:
|
690M |
|
|
|
|
MeiraGTx Holdings plc, a clinical-stage gene therapy company, focusing on developing treatments for patients living with serious diseases. The company develops various therapies for ocular diseases, including rare inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; neurodegenerative diseases, such as amyothrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program. The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. The company was founded in 20 |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
20.501 - 20.613 |
20.613 - 20.706 |
|
Low:
|
18.248 - 18.377 |
18.377 - 18.485 |
|
Close:
|
18.682 - 18.883 |
18.883 - 19.049 |
|
Technical analysis |
as of: 2020-02-14 4:30:42 PM |
|
Overall:
|
  |
| Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 23.25 One year: 25.43 |
| Support: |
Support1: 16.89 Support2: 14.05 |
| Resistance: |
Resistance1: 19.91 Resistance2: 21.77 |
| Pivot: |
19.26  |
| Moving Average: |
MA(5): 20.36 MA(20): 19.26
MA(100): 17.83 MA(250): 19.94 |
| MACD: |
MACD(12,26): 0.16 Signal(9): 0.04 |
| Stochastic oscillator: |
%K(14,3): 70.05 %D(3): 85.48 |
| RSI: |
RSI(14): 44.52 |
| 52-week: |
High: 30.23 Low: 12.00 Change(%): 47.4 |
| Average Vol(K): |
3-Month: 15392 10-Days: 9971 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.MGTX has closed above bottom band by 41.6%. Bollinger Bands are 29.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
2019-07-03
The Daily Biotech Pulse: Roche's Flu Drug Aces Late-Stage Trial, Acura Outlicenses Pain Medication, Neuronetics Gets New Finance Chief
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 2) ANI Pharmaceuticals Inc Common Stock (NASDAQ: ANIP ) ArQule, Inc. (NASDAQ: ARQL ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Coherus Biosciences Inc (NASDAQ: CHRS ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) MeiraGTx Holdings PLC (NASDAQ: MGTX ) ZEALAND PHARMA/S ADR (NASDAQ: ZEAL ) Down In The Dumps (Biotech stocks hitting 52-week lows on July 2) Adamis Pharmaceuticals Corp (NASDAQ: ADMP ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Atreca Inc (NASDAQ: BCEL )(IPOed June 20) Biopharmx Corp (NYSE: BPMX ) ContraVir Pharmaceuticals Inc (NASDAQ: CTRV ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Nuvectra Corp (NASDAQ: NVTR ) Personalis Inc (NASDAQ: PSNL ) (IPOed June 20) Prevail Therapeutics Inc (NASDAQ: PRVL ) (IPOed June 20) Sienna Biopharmaceuticals Inc (NASDAQ: SNNA ) Surface Oncology Inc (NASDAQ: SURF ) Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH ) TrovaGene Inc (NASDAQ: TROV ) See Also: Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates Stocks In Focus Roche's Flu Medication Found Effective And Safe In Children Roche Holdings AG Basel …
2019-07-02
The Daily Biotech Pulse: Celyad To Advance Leukemia Drug To Clinical Trial, Positive Data For Teva's Migraine Drug
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 1) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) Argenx SE – ADR (NASDAQ: ARGX ) ArQule, Inc. (NASDAQ: ARQL ) Axsome Therapeutics Inc (NASDAQ: AXSM ) (the company's stock has been added to Russell 3000 and Russell 2000 Indexes) Coherus Biosciences Inc (NASDAQ: CHRS )(announced that it has produced over 400,000 Udenyca pre-filled syringes to date) Fate Therapeutics Inc (NASDAQ: FATE ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) MeiraGTx Holdings PLC (NASDAQ: MGTX ) Misonix, Inc. (NASDAQ: MSON ) (the company's stock has been added to Russell 3000 and Russell 2000 Indexes) Morphic Holding Inc (NASDAQ: MORF )(IPOed June 27) Odonate Therapeutics Inc (NASDAQ: ODT ) Ra Pharmaceuticals Inc (NASDAQ: RARX ) ResMed Inc. (NYSE: RMD ) Tricida Inc (NASDAQ: TCDA ) Vapotherm Inc (NYSE: VAPO ) Zai Lab Ltd (NASDAQ: ZLAB ) Down In The Dumps (Biotech stocks hitting 52-week lows on July 1) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Artelo Biosciences Inc (NASDAQ: ARTL ) CELLECT …
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NasdaqGS |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
36.57 |
| Shares Float (M) |
11.72 |
|
% Held by Insiders
|
38.10 |
|
% Held by Institutions
|
44.55 |
|
Shares Short (K)
|
756 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-2.290 |
|
Book Value (p.s.)
|
5.330 |
|
PEG Ratio
|
-3.76 |
|
Profit Margin
|
|
|
Operating Margin
|
-1149.31 |
|
Return on Assets (ttm)
|
-21.6 |
|
Return on Equity (ttm)
|
-48.3 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-1.939 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
30.55 |
|
Levered Free Cash Flow (M)
|
-29.72 |
Stock Valuations |
|
P/E
|
-8.24 |
|
P/E Growth Ratio
|
-0.08 |
|
P/BV
|
3.54 |
|
P/S
|
89.90 |
|
P/CF
|
22.60 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
